SUNLIGHT Study: Online Support Groups for MS to Address COVID-19
SUNLIGHT Study: Online Support Groups for Multiple Sclerosis (MS) to Address COVID-19
What it found
We found no results in the registry or in papers.
This trial finished 6 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Online support Group
What it measured
Main measures
Rate of completion
Up to 12 weeks
Rate of adherence
Up to 12 weeks
Quality of life (reported by participants)
Other measures (1)
Score on the State Trait Anxiety Inventory (STAI)
Up to 12 weeks
Mood and sleep
Who could take part
MS (type not specified) · 18 and over
Show the full criteria
Inclusion criteria
* MS Diagnosis * 18 years or older
Exclusion criteria
* None
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Stress and anxiety can have an adverse impact on health, and the experience of many around the 2020 outbreak of COVID-19 is affecting health and well-being. Individuals with chronic disease such as multiple sclerosis may be particularly vulnerable in some ways, but also particularly resilient in others. This study evaluates the effects of belonging to online support groups that meet weekly for 12 weeks to address the stress and anxiety felt by individuals with Multiple Sclerosis (MS). This study will also measure and explore the effects of online support groups.
Papers
Loading reviews and guidelines…
History
Started
May 2020
Main results due
Jul 2020
Finished
Aug 2020